JP2008505117A5 - - Google Patents

Download PDF

Info

Publication number
JP2008505117A5
JP2008505117A5 JP2007519511A JP2007519511A JP2008505117A5 JP 2008505117 A5 JP2008505117 A5 JP 2008505117A5 JP 2007519511 A JP2007519511 A JP 2007519511A JP 2007519511 A JP2007519511 A JP 2007519511A JP 2008505117 A5 JP2008505117 A5 JP 2008505117A5
Authority
JP
Japan
Prior art keywords
substituted
unsubstituted
alkyl
cycloalkyl
heteroalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2007519511A
Other languages
English (en)
Japanese (ja)
Other versions
JP4958774B2 (ja
JP2008505117A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2005/023675 external-priority patent/WO2006014394A1/en
Publication of JP2008505117A publication Critical patent/JP2008505117A/ja
Publication of JP2008505117A5 publication Critical patent/JP2008505117A5/ja
Application granted granted Critical
Publication of JP4958774B2 publication Critical patent/JP4958774B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2007519511A 2004-07-02 2005-06-29 改変されたピリミジン糖質コルチコイドレセプター調節因子 Expired - Fee Related JP4958774B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US58501804P 2004-07-02 2004-07-02
US60/585,018 2004-07-02
PCT/US2005/023675 WO2006014394A1 (en) 2004-07-02 2005-06-29 Modified pyrimidine glucocorticoid receptor modulators

Publications (3)

Publication Number Publication Date
JP2008505117A JP2008505117A (ja) 2008-02-21
JP2008505117A5 true JP2008505117A5 (US07794700-20100914-C00152.png) 2008-07-17
JP4958774B2 JP4958774B2 (ja) 2012-06-20

Family

ID=35311764

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007519511A Expired - Fee Related JP4958774B2 (ja) 2004-07-02 2005-06-29 改変されたピリミジン糖質コルチコイドレセプター調節因子

Country Status (17)

Country Link
US (2) US7576076B2 (US07794700-20100914-C00152.png)
EP (1) EP1778236B1 (US07794700-20100914-C00152.png)
JP (1) JP4958774B2 (US07794700-20100914-C00152.png)
KR (1) KR101210730B1 (US07794700-20100914-C00152.png)
AT (1) ATE473744T1 (US07794700-20100914-C00152.png)
AU (1) AU2005270039B2 (US07794700-20100914-C00152.png)
CA (1) CA2572544C (US07794700-20100914-C00152.png)
CY (1) CY1110828T1 (US07794700-20100914-C00152.png)
DE (1) DE602005022319D1 (US07794700-20100914-C00152.png)
DK (1) DK1778236T3 (US07794700-20100914-C00152.png)
ES (1) ES2348667T3 (US07794700-20100914-C00152.png)
HK (1) HK1097768A1 (US07794700-20100914-C00152.png)
IL (1) IL180508A0 (US07794700-20100914-C00152.png)
NZ (1) NZ552984A (US07794700-20100914-C00152.png)
PT (1) PT1778236E (US07794700-20100914-C00152.png)
WO (1) WO2006014394A1 (US07794700-20100914-C00152.png)
ZA (1) ZA200700616B (US07794700-20100914-C00152.png)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102127057A (zh) * 2004-03-15 2011-07-20 武田药品工业株式会社 二肽基肽酶抑制剂
JP2008524331A (ja) * 2004-12-21 2008-07-10 武田薬品工業株式会社 ジペプチジルペプチダーゼ阻害剤
ZA200802857B (en) 2005-09-14 2009-09-30 Takeda Pharmaceutical Dipeptidyl peptidase inhibitors for treating diabetes
JPWO2008018592A1 (ja) * 2006-08-11 2010-01-07 大正製薬株式会社 プロスタグランジン誘導体含有外用剤
TWI410422B (zh) 2007-01-15 2013-10-01 Mitsubishi Tanabe Pharma Corp 縮合四氫喹啉衍生物及其醫藥用途
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
EP2211845B1 (en) 2007-10-17 2017-02-22 Laboratoire HRA Pharma Glucocorticoid receptor antagonists such as mifepristone for treating cushing's syndrome
US9216221B2 (en) 2008-11-07 2015-12-22 University Of Sheffield Medicament and method of diagnosis for treating subclinical Cushing's syndrome
AU2012231265B2 (en) 2011-03-18 2016-07-07 Corcept Therapeutics, Inc. Pyrimidine cyclohexyl glucocorticoid receptor modulators
EP3434274A1 (en) * 2011-03-31 2019-01-30 Pop Test Oncology LLC Prevention of infection
US8859774B2 (en) 2012-05-25 2014-10-14 Corcept Therapeutics, Inc. Heteroaryl-ketone fused azadecalin glucocorticoid receptor modulators
WO2016032127A2 (ko) * 2014-08-25 2016-03-03 부산대학교 산학협력단 Tlr4에 lps와의 경쟁적 결합을 통한 항산화 및 항염증 활성을 갖는 신규 화합물 및 이의 의학적 용도
KR101686872B1 (ko) * 2014-08-25 2016-12-20 부산대학교 산학협력단 Tlr4에 lps와의 경쟁적 결합을 통한 항산화 및 항염증 활성을 갖는 신규 화합물 및 이의 의학적 용도
US10183949B2 (en) 2014-08-29 2019-01-22 The University Of Tokyo Pyrimidinone derivative having autotaxin-inhibitory activity
KR20180052120A (ko) 2015-08-13 2018-05-17 코어셉트 쎄라퓨틱스, 잉크. Acth-의존성 쿠싱 증후군을 감별 진단하는 방법
CA3011728A1 (en) 2016-01-19 2017-07-27 Corcept Therapeutics, Inc. Differential diagnosis of ectopic cushing's syndrome
KR102342620B1 (ko) 2017-03-31 2021-12-22 코어셉트 쎄라퓨틱스 인코포레이티드 자궁경부암을 치료하기 위한 글루코코르티코이드 수용체 조정제
US11542248B2 (en) * 2017-06-08 2023-01-03 Kura Oncology, Inc. Methods and compositions for inhibiting the interaction of menin with MLL proteins
WO2019060365A1 (en) 2017-09-20 2019-03-28 Kura Oncology, Inc. SUBSTITUTED MÉNINE-MLL INHIBITORS AND METHODS OF USE
WO2019236487A1 (en) * 2018-06-04 2019-12-12 Corcept Therapeutics Incorporated Pyrimidine cyclohexenyl glucocorticoid receptor modulators
US11234971B2 (en) 2018-12-19 2022-02-01 Corcept Therapeutics Incorporated Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
KR102657097B1 (ko) 2018-12-19 2024-04-15 코어셉트 쎄라퓨틱스 인코포레이티드 헤테로아릴-케톤 융합 아자데칼린 화합물인 렐라코릴란트를 함유하는 약학적 제제
WO2020132046A1 (en) 2018-12-19 2020-06-25 Corcept Therapeutics Incorporated Methods of treating cancer comprising administration of a glucocorticoid receptor modulator and a cancer chemotherapy agent
US11903945B2 (en) 2019-12-11 2024-02-20 Corcept Therapeutics Incorporated Methods of treating antipsychotic-induced weight gain with miricorilant
CA3182272A1 (en) 2020-05-06 2021-11-11 Corcept Therapeutics Incorporated Polymorphs of pyrimidine cyclohexyl glucocorticoid receptor modulators
CA3202353A1 (en) 2020-12-21 2022-06-30 Jeffrey Mark Dener Method of preparing pyrimidine cyclohexyl glucocorticoid receptor modulators

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3011809A1 (de) * 1980-03-27 1981-10-01 Cassella Ag, 6000 Frankfurt Pyrimidyl-chinazoline, verfahren zu ihrer herstellung, sie enthaltende pharmazeutische praeparate und ihre verwendung
US5008267A (en) 1988-10-29 1991-04-16 Mitsui Toatsu Chemicals, Incorporated Pyrimidinedione compounds, method of producing the same and antiarrythmic agents containing the same
JPH06128238A (ja) 1992-10-20 1994-05-10 Mitsui Toatsu Chem Inc 新規ピリミジンジオン誘導体
EP0722732A1 (en) 1995-01-24 1996-07-24 Mitsui Toatsu Chemicals, Inc. Long-acting drug formulation containing pyrimidinedione derivatives
JPH1017555A (ja) * 1996-07-02 1998-01-20 Mitsui Petrochem Ind Ltd 6−アミノ−5−メチルウラシル誘導体
DE60113032T2 (de) * 2000-10-30 2006-07-06 Pfizer Products Inc., Groton Glukokortikoidrezeptor-Modulatoren
GB0029100D0 (en) * 2000-11-29 2001-01-10 Karobio Ab Compounds active at the glucocorticoid receptor
JP2003017555A (ja) 2001-06-29 2003-01-17 Hitachi Ltd 半導体集積回路装置およびその製造方法
US20030232813A1 (en) 2002-04-10 2003-12-18 Orchid Chemicals & Pharmaceuticals Limited Novel amino substituted pyrimidinone derivatives

Similar Documents

Publication Publication Date Title
JP2008505117A5 (US07794700-20100914-C00152.png)
JP2007528417A5 (US07794700-20100914-C00152.png)
JP2004516314A5 (US07794700-20100914-C00152.png)
JP2008505157A5 (US07794700-20100914-C00152.png)
JP2009530424A5 (US07794700-20100914-C00152.png)
JP2010511721A5 (US07794700-20100914-C00152.png)
JP2006524222A5 (US07794700-20100914-C00152.png)
JP2004523561A5 (US07794700-20100914-C00152.png)
ATE14423T1 (de) Hydroxamsaeurederivate vom typ der mannich-basen mit verbesserter biologischer verfuegbarkeit von nicht-steroiden entzuendungshemmern, verfahren zur herstellung und diese verbindungen enthaltende pharmazeutische zusammensetzung.
JP2004529874A5 (US07794700-20100914-C00152.png)
JP2012510502A5 (US07794700-20100914-C00152.png)
JP2007524696A5 (US07794700-20100914-C00152.png)
JP2005508905A5 (US07794700-20100914-C00152.png)
JP2009534468A5 (US07794700-20100914-C00152.png)
JP2008533191A5 (US07794700-20100914-C00152.png)
JP2005532287A5 (US07794700-20100914-C00152.png)
JP2009534398A5 (US07794700-20100914-C00152.png)
JP2006509749A5 (US07794700-20100914-C00152.png)
JP2006514626A5 (US07794700-20100914-C00152.png)
RU2005109913A (ru) Азабициклоалкильные эфиры и их применение в качестве агонистов альфа7-nachr
RU2006130686A (ru) Новые пиперидины в качестве модуляторов хемокинов (ccr)
JP2007504235A5 (US07794700-20100914-C00152.png)
JP2006509842A5 (US07794700-20100914-C00152.png)
JP2005511594A5 (US07794700-20100914-C00152.png)
JP2018515550A5 (US07794700-20100914-C00152.png)